DOCK2 and liver cancer: Given that different DOCK2 mutation types may have different effects on the occurrence of liver cancer, this study further divided the gene expression data of 28 DOCK2 mutant LIHC patients into two subgroups: the inactivated mutation subgroup (n = 8, containing nonsense mutation and silent mutation) and other non-silent mutation subgroups (n = 20).